CHEYENNE HAMBLIN: Open Payments
NPI 1801657424 · LONDON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 76 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $947 · 2025 $1,509
Food & beverage: $1,509
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $263 |
| Otsuka America Pharmaceutical, Inc. | 11 | $243 |
| Teva Pharmaceuticals USA, Inc. | 8 | $241 |
| Vanda Pharmaceuticals Inc. | 12 | $199 |
| Collegium Pharmaceutical, Inc. | 1 | $125 |
| Janssen Pharmaceuticals, Inc | 4 | $116 |
| Indivior Inc. | 5 | $79 |
| ABBVIE INC. | 4 | $61 |
| Almatica Pharma LLC | 2 | $48 |
| Axsome Therapeutics, Inc. | 2 | $38 |
Products named: CAPLYTA, REXULTI, AUSTEDO XR, HETLIOZ, Jornay PM, SPRAVATO, SUBLOCADE, FANAPT.
Industry payments across KY — which companies pay providers there.
